Login / Signup
Ayman A Ibrahim
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Protein Kinase
Oxide Nanoparticles
Transforming Growth Factor
Liver Fibrosis
Top Venues
Naunyn-Schmiedeberg's archives of pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Heba M Karam
,
Dina M Lotfy
,
Ayman A Ibrahim
,
Farag M Mosallam
,
Sahar S Abdelrahman
,
Amira Abd-ElRaouf
A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway.
Naunyn-Schmiedeberg's archives of pharmacology
(2024)
Heba M Karam
,
Dina M Lotfy
,
Ayman A Ibrahim
,
Farag M Mosallam
,
Sahar S Abdelrahman
,
Amira Abd-ElRaouf
A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway.
Naunyn-Schmiedeberg's archives of pharmacology
(2024)
Heba M Karam
,
Dina M Lotfy
,
Ayman A Ibrahim
,
Farag M Mosallam
,
Sahar S Abdelrahman
,
Amira Abd-ElRaouf
Correction to: A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway.
Naunyn-Schmiedeberg's archives of pharmacology
(2024)